The adverse prognostic impact of metabolic syndrome (METS) in unselected populations and in patients with coronary heart disease has been previously shown. The aim of the current analysis was to evaluate the impact of METS on prognosis in chronic heart failure (HF).
Prognostic Impact of Metabolic Syndrome in Patients With Chronic Heart Failure: Data From Gissi-Hf Trial / Savarese, G; PERRONE FILARDI, Pasquale; Scarano, M; Cavazzina, R; Trimarco, Bruno; Minneci, S; Maggioni, Ap; Tavazzi, L; Tognoni, G; Marchioli, R.. - In: CIRCULATION. - ISSN 0009-7322. - 128:(2013), pp. A17342-A17342. [10.1016/j.ijcard.2014.10.094]
Prognostic Impact of Metabolic Syndrome in Patients With Chronic Heart Failure: Data From Gissi-Hf Trial
PERRONE FILARDI, PASQUALE;TRIMARCO, BRUNO;
2013
Abstract
The adverse prognostic impact of metabolic syndrome (METS) in unselected populations and in patients with coronary heart disease has been previously shown. The aim of the current analysis was to evaluate the impact of METS on prognosis in chronic heart failure (HF).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
